Mednet Logo
HomeQuestion

Would you transition from denosumab to anabolic agents in patients who are in urgent need for extensive dental work?

6
2 Answers
Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

From my experience, this is a catch-22. If you stop the Denosumab you will markedly increase osteoclastic activity throughout the entire skeleton which is why it is recommended that you not stop the medication without some other intervention. I have had several patients with either osteonecrosis of ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

I agree with Dr. @Dr. First Last. Teriparatide and abaloparatide are remodeling-based anabolic drugs. When you stop denosumab there is increased osteoclastic activity and loss of BMD. If you start a PTH anabolic the anabolic response is often quite robust Ignore BMD for a second and think about the ...

Register or Sign In to see full answer